Introduction
This entry reviews five major categories of psychopharmacological medications used to treat mood disorders, anxiety disorders, bipolar disorders, psychotic disorders, and attention-deficit/hyperactivity disorder. The term adjunctive distinguishes how therapists should approach medication. Medication should be viewed as supplemental. Only one role of the therapist is as medication manager with tasks like identifying target symptoms to treat with medications, assessing medication responsiveness, confirming use as directed, coping with side effects, and working with the prescribing physician.
Theoretical Framework
The systemic perspective notes multiple influences on the client. Therapists treat the whole family to use relationships to heal. Working with the family provides the best support for the individual using psychotropic medication. Yet, the medical model should be incorporated into therapy to ensure the client is receiving the best standard of care. For example,...
This is a preview of subscription content, log in via an institution to check access.
References
DeSousa, A., & Kalra, G. (2012). Drug therapy of attention deficit hyperactivity disorder: Current trends. Mens Sana Monigraphs, 10, 45–69.
Girardi, P., Brugnoli, R., Manfredi, G., & Sani, G. (2016). Lithium in bipolar disorder: Optimizing therapy using prolonged-release formulations. Drugs in R&D, 16, 293–302.
Mancini, K., & Luebbe, A. (2016). Dyadic affective flexibility and emotional inertia in relation to youth psychopathology: An integrated model at two timescales. Clinical Child and Family Psychology Review, 19, 117–133.
McIntosh, A., Cohen, A., Turnbull, N. et al. (2004). Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. National Collaborating Centre for Primary Care.
Meyer, D. (2014). Candidates for Antidepressants: Assessing a history of early life stressors CounselingVistas. Retrieved from http://www.counseling.org/docs/default-source/vistas/article_65.pdf?Sfvrsn=8
Nicolas, G., Desilva, A., Prater, K., & Bronkoski, E. (2009). Empathic family stress as a sign of family connectedness in Haitian immigrants. Family Process, 48, 135–150.
Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72, 136–142.
Poon, S., Sim, K., & Baldessarini, R. (2015). Pharmacological approaches for treatment-resistant bipolar disorder. Current Neuropharmacology, 13, 592–604.
Smith, T., Weston, C., & Lieberman, J. (2010). Schizophrenia (maintenance treatment). American Family Physician, 82, 338–339.
Weitz, E., Hollon, S., Twisk, J., et al. (2015). Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs. pharmacotherapy: An individual patient data meta-analysis. JAMA Psychiatry, 72, 1102–1109.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Meyer, D., Barkley, S. (2017). Adjunctive Psychopharmacology in Couple and Family Therapy. In: Lebow, J., Chambers, A., Breunlin, D. (eds) Encyclopedia of Couple and Family Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-15877-8_421-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-15877-8_421-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15877-8
Online ISBN: 978-3-319-15877-8
eBook Packages: Springer Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences